Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
Open Access
- 24 April 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 7, 170
- https://doi.org/10.3389/fmed.2020.00170
Abstract
The aim was to investigate the effectiveness of glucocorticoid therapy in patients with COVID-19. A systematic search of the literature across nine databases was conducted from inception until 15th March 2020, following the PRISMA guidelines. Patients with a validated diagnosis of COVID-19 and using corticosteroids were included, considering all health outcomes. Four studies with 542 Chinese participants were included. Two studies reported negative findings regarding the use of corticosteroids in patients with COVID-19, i.e., corticosteroids had a detrimental impact on clinical outcomes. One study reported no significant association between the use of corticosteroids and clinical outcomes. However, one study, on 201 participants with different stages of pneumonia due to COVID-19, found that in more severe forms, the administration of methylprednisolone significantly reduced the risk of death by 62%. The literature to date does not fully support the routine use of corticosteroids in COVID-19, but some findings suggest that methylprednisolone could lower mortality rate in more severe forms of the condition.This publication has 39 references indexed in Scilit:
- Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literatureIntensive Care Medicine, 2015
- Use of Corticosteroids in Treating Infectious DiseasesJAMA Internal Medicine, 2008
- Corticosteroid treatment of severe acute respiratory syndrome in Hong KongJournal of Infection, 2007
- SARS: Systematic Review of Treatment EffectsPLoS Medicine, 2006
- Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patientsJournal of Clinical Virology, 2004
- Effect of Corticosteroid on Lung Parenchyma Remodeling at an Early Phase of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Our Strategies for Fighting Severe Acute Respiratory Syndrome (SARS)American Journal of Respiratory and Critical Care Medicine, 2003
- A Major Outbreak of Severe Acute Respiratory Syndrome in Hong KongThe New England Journal of Medicine, 2003
- Prolonged Methylprednisolone Treatment Suppresses Systemic Inflammation in Patients with Unresolving Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000